In the company’s exhibit, Teijin will present its high-performance materials and composites technologies that can improve manufacturing cycle times, reduce environmental impact and improve consumer ...

Merck & Co is looking to improve its neurology pipeline via a deal with Teijin Pharma to develop a new tau-targeting antibody. The tau protein is implicated in a number of nervous system ...